Metreleptin
美曲普汀
Report date: 2022/03/07 18:01:42
First In Class
Base Information
Drug NameMetreleptin
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2013/03/25
Country/Territory +[14]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcAmylin PharmaceuticalBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesMedison PharmaAmryt PharmaChiesi Farmaceutici SPA +[5]
Inactive CompaniesUniversity of Texas Southwestern Medical CenterAmylin Pharmaceuticals LlcAstrazeneca Plc +[7]
Active Indications +[6]
Inactive Indications +[6]